| Literature DB >> 34419372 |
Lorriana E Leard1, Are M Holm2, Maryam Valapour3, Allan R Glanville4, Sandeep Attawar5, Meghan Aversa6, Silvia V Campos7, Lillian M Christon8, Marcelo Cypel6, Göran Dellgren9, Matthew G Hartwig10, Siddhartha G Kapnadak11, Nicholas A Kolaitis12, Robert M Kotloff13, Caroline M Patterson14, Oksana A Shlobin15, Patrick J Smith10, Amparo Solé16, Melinda Solomon17, David Weill18, Marlies S Wijsenbeek19, Brigitte W M Willemse20, Selim M Arcasoy21, Kathleen J Ramos11.
Abstract
Tens of thousands of patients with advanced lung diseases may be eligible to be considered as potential candidates for lung transplant around the world each year. The timing of referral, evaluation, determination of candidacy, and listing of candidates continues to pose challenges and even ethical dilemmas. To address these challenges, the International Society for Heart and Lung Transplantation appointed an international group of members to review the literature, to consider recent advances in the management of advanced lung diseases, and to update prior consensus documents on the selection of lung transplant candidates. The purpose of this updated consensus document is to assist providers throughout the world who are caring for patients with pulmonary disease to identify potential candidates for lung transplant, to optimize the timing of the referral of these patients to lung transplant centers, and to provide transplant centers with a framework for evaluating and selecting candidates. In addition to addressing general considerations and providing disease specific recommendations for referral and listing, this updated consensus document includes an ethical framework, a recognition of the variability in acceptance of risk between transplant centers, and establishes a system to account for how a combination of risk factors may be taken into consideration in candidate selection for lung transplantation.Entities:
Keywords: chronic obstructive pulmonary disease; consensus; cystic fibrosis; emphysema; ethics; interstitial lung disease; lung transplant; pulmonary hypertension; risk factor
Mesh:
Year: 2021 PMID: 34419372 PMCID: PMC8979471 DOI: 10.1016/j.healun.2021.07.005
Source DB: PubMed Journal: J Heart Lung Transplant ISSN: 1053-2498 Impact factor: 13.569